PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification ...

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound ...

The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...

Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers ...